Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Guselkumab in Plaque psoriasis: NCT07532486 Clinical Landscape Report 2026
18 September 2026
NCT07532486 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07539818 Clinical Landscape Report 2026
18 September 2026
NCT07539818 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fluticasone Propionate in Eczema: NCT07537751 Clinical Landscape Report 2026
18 September 2026
NCT07537751 clinical landscape for Eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HLX316 in Hepatocellular Carcinoma: NCT07541534 Clinical Landscape Report 2026
18 September 2026
NCT07541534 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
KMA.CAR T(HaemaLogiX) in Refractory Multiple Myeloma: NCT07541391 Clinical Landscape Report 2026
18 September 2026
NCT07541391 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Melphalan in Extramedullary Disease in Multiple Myeloma: NCT07542418 Clinical Landscape Report 2026
18 September 2026
NCT07542418 clinical landscape for Extramedullary Disease in Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Becotatug vedotin in Recurrent Cervical Cancer: NCT07542717 Clinical Landscape Report 2026
18 September 2026
NCT07542717 clinical landscape for Recurrent Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivarmacitinib in Dermatitis, Atopic: NCT07550452 Clinical Landscape Report 2026
18 September 2026
NCT07550452 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tapinarof in Plaque psoriasis: NCT07546214 Clinical Landscape Report 2026
18 September 2026
NCT07546214 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cyclophosphamide in Acute Myeloid Leukemia: NCT07548983 Clinical Landscape Report 2026
18 September 2026
NCT07548983 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HXN-5003 in Dermatitis, Atopic: NCT07549750 Clinical Landscape Report 2026
18 September 2026
NCT07549750 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PLM-102 in Relapsing acute myeloid leukemia: NCT07549464 Clinical Landscape Report 2026
18 September 2026
NCT07549464 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…